COVID vaccine from Md.-based Novavax gets preliminary approval in the UK

Gaithersburg, Maryland-based Novavax, which filed for U.S. FDA approval for its protein-based COVID-19 vaccine Monday, has received conditional approval for the vaccine from UK regulators.